![Thane Wettig](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thane Wettig
Chief Executive Officer at
KYNTRA BIO, INC.
Net worth: 204 190 $ as of 2026-06-29
Profile
Thane Wettig is Chief Executive Officer & Director at Kyntra Bio, Inc. since 2023.
Former roles include Chief Commercial Officer at Intarcia Therapeutics, Inc. and Vice President-Diabetes Brands Global Marketing at Lilly Diabetes from 2004 to 2009.
Education includes undergraduate and MBA degrees from Washington University in St. Louis.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
KYNTRA BIO, INC. 0.67% | 2026-06-05 | 27,045 ( 0.67% ) | 204 190 $ | 2026-06-29 |
Thane Wettig active positions
| Companies | Position | Start |
|---|---|---|
| KYNTRA BIO, INC. | Chief Executive Officer | 2023-07-22 |
Former positions of Thane Wettig
| Companies | Position | End |
|---|---|---|
Lilly Diabetes | Corporate Officer/Principal | 2008-12-31 |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Corporate Officer/Principal | - |
Training of Thane Wettig
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
13
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FibroGen, Inc.
 FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Health Technology |
Lilly Diabetes |
- Stock Market
- Insiders
- Thane Wettig
Choose MarketScreener 
